The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
Category: Food and Drug Administration
-
F.D.A. Drug Unit Chief Is Placed on Leave, and Cites a ‘Toxic’ Environment
The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
-
Candy Companies Are Quietly Cutting Down on Cocoa to Save Money
As climate change has helped push cocoa prices higher, companies are changing candy recipes in subtle ways.
-
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
-
Texas Sues Tylenol Makers, Claiming They Hid Autism Risks
The lawsuit follows claims by President Trump that linked use by pregnant women of acetaminophen to autism, a connection that is unproven.
-
Neutrogena Recalls Makeup Wipes Over Bacterial Contamination Concerns
The recalled wipes were distributed in Florida, Georgia, South Carolina and Texas, according to the Food and Drug Administration.
-
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
-
Trump Rattles Vaccine Experts Over Aluminum
The president’s call for removal of the metal from childhood inoculations set off alarms. About half of shots for polio, whooping cough and other diseases would be affected.
-
F.D.A.’s Approval of Drug for Autism Upends Review Process
The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.
-
FDA OKs New Keytruda Shot for Cancer
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
-
F.D.A. Reviews Cases of Covid Vaccine Deaths
The agency plans to present accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.